Detalhe da pesquisa
1.
Health-related quality of life in women with breast cancer: a review of measures.
BMC Cancer
; 22(1): 66, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033009
2.
The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
Lung
; 198(1): 65-86, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722043
3.
Psychometric Evaluation of the Patient's Knee Implant Performance Questionnaire.
Value Health
; 21(11): 1305-1312, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442278
4.
A Review of Patient-Reported Outcome Labeling in the United States (2011-2015).
Value Health
; 20(3): 420-429, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292487
5.
Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept.
J Am Acad Dermatol
; 76(4): 655-661, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087133
6.
Development of a scale to assess performance following primary total knee arthroplasty.
Value Health
; 17(4): 350-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24968994
7.
Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010).
Value Health
; 16(8): 1150-5, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24326168
8.
Potential of patient-reported outcomes as nonprimary endpoints in clinical trials.
Health Qual Life Outcomes
; 11: 83, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23675876
9.
Evidence-based medicine, appropriate-use criteria, and sports medicine: how best to develop meaningful treatment guidelines.
Arthroscopy
; 29(7): 1224-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510944
10.
Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.
Cancer Med
; 12(12): 13637-13648, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306665
11.
A review of patient-reported outcome labels in the United States: 2006 to 2010.
Value Health
; 15(3): 437-42, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22583453
12.
Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010.
Value Health
; 15(3): 443-8, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22583454
13.
Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee in the United States: A Systematic Review of Economic Evaluations.
Clin Med Insights Arthritis Musculoskelet Disord
; 14: 11795441211047284, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34840501
14.
Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab.
Clin Drug Investig
; 39(12): 1205-1212, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549346
15.
A Pilot Study to Assess the Feasibility of a Web-Based Survey to Examine Patient-Reported Symptoms and Satisfaction in Patients with Ankylosing Spondylitis Receiving Secukinumab.
Drugs Real World Outcomes
; 6(2): 83-91, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054047
16.
Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab.
J Dermatolog Treat
; 28(6): 492-499, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28266243
17.
Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis.
J Dermatolog Treat
; 28(5): 384-389, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27832717
18.
Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis.
Int J Dermatol
; 55(3): e147-55, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26518255
19.
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.
Int J Dermatol
; 55(4): 401-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26866518
20.
Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.
Am J Clin Dermatol
; 4(2): 131-9, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12553852